Cite
HARVARD Citation
Galeone, A. et al. (2022). Suppression of tumorigenicity‐2 (ST2) is a promising biomarker in heart transplantation. Clinical transplantation. 36 (5), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Galeone, A. et al. (2022). Suppression of tumorigenicity‐2 (ST2) is a promising biomarker in heart transplantation. Clinical transplantation. 36 (5), p. n/a. [Online].